ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,273,791 | -24.7% | 47,458 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,691,939 | -89.6% | 47,453 | -92.6% | 0.00% | -90.9% |
| Q1 2023 | $16,308,716 | -28.9% | 642,057 | +13.5% | 0.01% | -31.2% |
| Q4 2022 | $22,952,751 | +21.9% | 565,908 | -50.3% | 0.02% | +14.3% |
| Q3 2022 | $18,831,813 | -6.4% | 1,138,466 | +99.2% | 0.01% | 0.0% |
| Q2 2022 | $20,120,000 | -40.2% | 571,430 | -21.9% | 0.01% | -12.5% |
| Q1 2022 | $33,645,000 | -47.5% | 731,564 | -24.3% | 0.02% | -40.7% |
| Q4 2021 | $64,090,000 | +6.9% | 966,685 | +0.7% | 0.03% | +3.8% |
| Q3 2021 | $59,948,000 | -36.6% | 960,232 | -15.9% | 0.03% | -35.0% |
| Q2 2021 | $94,547,000 | +25.0% | 1,141,595 | +0.1% | 0.04% | +14.3% |
| Q1 2021 | $75,614,000 | -14.0% | 1,140,313 | -0.4% | 0.04% | -14.6% |
| Q4 2020 | $87,890,000 | +76.2% | 1,145,443 | -1.1% | 0.04% | +57.7% |
| Q3 2020 | $49,883,000 | +24.5% | 1,158,462 | +24.9% | 0.03% | +18.2% |
| Q2 2020 | $40,072,000 | – | 927,799 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,328 | $51,213,000 | 30.37% |
| JOHNSON & JOHNSON | 3,260,869 | $203,576,000 | 17.86% |
| ACT CAPITAL MANAGEMENT, LLC | 194,000 | $12,111,000 | 6.28% |
| Aquilo Capital Management, LLC | 527,926 | $32,958,000 | 5.99% |
| Evolutionary Tree Capital Management, LLC | 105,491 | $6,586,000 | 2.92% |
| ACUTA CAPITAL PARTNERS, LLC | 121,500 | $7,585,000 | 2.68% |
| L1 Capital Pty Ltd | 297,915 | $18,599,000 | 2.31% |
| Avidity Partners Management LP | 673,700 | $42,059,000 | 0.93% |
| Hood River Capital Management LLC | 338,734 | $21,147,000 | 0.65% |
| Tygh Capital Management, Inc. | 64,127 | $4,003,000 | 0.54% |